现代玻璃体切除术中术后第一天眼压复查的作用
该回顾性连续病例复习纳入2013年4月至6月在某大型三级转诊中心接受23G玻璃体切除术的200例(89%)患者,评估术后第一天复查是否发现改变处理方案的并发症及术后眼压升高的危险因素。结果显示第一天复查发现不良事件的比例为0.5%,联合激光是第一天眼压升高的唯一危险因素(p=0.005),22%患者因早期眼压升高接受治疗但无长期并发症。
要点
- 200例中176例(89.3%)行术后第一天复查,24例(12%)于第2周复查,2例(1%)因早期眼压并发症需紧急手术干预。
- 联合激光是第一天眼压升高的唯一危险因素(p=0.005)。
- 44例(22%)在玻璃体切除术后2周内因眼压升高接受治疗,这些患者未发现长期并发症。
核心结论
- 术后第一天复查在0.5%的研究患者中发现了不良事件。
- 在接受早期术后眼压升高治疗的22%患者中未报告长期并发症。
- 这一观察导致研究机构在常规无并发症玻璃体切除术后从手术护理路径中移除了常规第一天复查。
研究设计与样本
- 回顾性、连续病例记录复习,纳入2013年4月至6月在研究机构接受23G玻璃体切除术的所有患者。
- 患者分别在术后第一天、第2周和第2个月评估,或第2周和第2个月评估。
- 采用线性回归分析识别眼压升高的危险因素。
主要发现
- 200例(89%)符合纳入标准,其中176例(89.3%)行第一天复查,24例(12%)于第2周就诊。
- 平均随访120天(范围20-360天)。
- 2例(1%)因早期眼压并发症需要紧急手术干预。
- 联合激光是第一天眼压升高的唯一危险因素(p=0.005)。
- 总计44例患者(22%)在玻璃体切除术后2周内因眼压升高接受治疗,这些患者未发现长期并发症。
关键数值与推荐
- 第一天复查发现不良事件的比例为0.5%。
- 联合激光与第一天眼压升高的关联p=0.005。
- 44例(22%)在术后2周内因眼压升高接受治疗。
临床怎么用
- 研究机构因上述观察,已在常规无并发症玻璃体切除术后从手术护理路径中移除常规第一天复查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the introduction of sutureless 23-gauge (23G) vitrectomy, the risks for elevated intraocular pressure (IOP) and the need for day 1 review of IOP are less certain. AIMS: To assess current practice for postoperative review in the vitreoretinal service at a large tertiary referral centre; to assess whether day 1 review detected complications altering patient management; to identify risk factors for IOP spikes postvitrectomy. METHODS: Retrospective, consecutive case note review of all patients undergoing 23G vitrectomy at the study institution between April and June 2013. Patients had assessment at either day 1, week 2 and month 2 or week 2 and month 2. Linear regression analysis was performed to identify risk factors for IOP elevation. RESULTS: 200 (89%) cases met inclusion criteria. Of these, 176 (89.3%) had day 1 review, 24 (12%) were seen at week 2. Mean follow-up was 120 days (range 20-360). Two cases (1%) required urgent surgical intervention due to early IOP complications. Combined laser was the only risk factor for a day 1 IOP spike (p=0.005). In total, 44 patients (22%) were treated for elevated IOP within 2 weeks following vitrectomy. No long-term complications were detected in these patients. CONCLUSIONS: Day 1 review detected adverse events in 0.5% of study patients. No long-term complications were reported in the 22% of patients who received treatment for early postoperative IOP elevation. This observation has led to the removal of routine day 1 review from the surgical care pathway following routine uncomplicated vitrectomy at the study institution.
引用
- Brennan N, Reekie I, Ezra E, et al. The role of day one postoperative review of intraocular pressure in modern vitrectomy surgery. Br J Ophthalmol. 2017. PMID: 28108568. doi:10.1136/bjophthalmol-2016-309664
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。